SEC Form 4 · accession 0001571049-17-007925
Semler Scientific, Inc. · SMLR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Sep 13, 2017
Accepted (ET)
Sep 15, 2017 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001554859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 13, 2017 | S | 20,000 | $3.3685 | D | 130,000 | D | |
| Common StockF2 | holding | — | — | — | 378,064 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.44 and the reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2These securities are held in family trusts and may be deemed to be beneficially owned by the reporting persons as beneficiaries and Co-Trustees of such trusts.